Balentine LLC’s Zimmer Biomet ZBH Stock Holding History

Balentine LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,516	Closed	-$369K	–	734
2022 Q2	$369K	Buy	3,516 +272	+8%	+$32.3K	0.01%	386
2022 Q1	$415K	Buy	+3,244	New	+$391K	0.01%	330
2021 Q4	–	Sell	-1,620	Closed	-$230K	–	465
2021 Q3	$230K	Buy	+1,620	New	+$238K	0.01%	219
2020 Q3	–	Sell	-625	Closed	-$72K	–	865
2020 Q2	$72K	Buy	625 +17	+3%	+$1.96K	﹤0.01%	186
2020 Q1	$60K	Buy	608 +8	+1%	+$1.05K	﹤0.01%	164
2019 Q4	$87K	Buy	600 +536	+838%	+$74K	﹤0.01%	131
2019 Q3	$9K	Buy	64 +30	+88%	+$3.88K	﹤0.01%	383
2019 Q2	$4K	Buy	+34	New	+$3.98K	﹤0.01%	569
2018 Q1	–	Sell	-559	Closed	-$66K	–	538
2017 Q4	$66K	Hold	559	–	–	0.01%	247
2017 Q3	$64K	Sell	559 -59	-10%	-$6.81K	0.01%	235
2017 Q2	$77K	Hold	618	–	–	0.01%	199
2017 Q1	$73K	Buy	618 +530	+602%	+$60.1K	0.01%	193
2016 Q4	$9K	Hold	88	–	–	﹤0.01%	417
2016 Q3	$11K	Hold	88	–	–	﹤0.01%	354
2016 Q2	$10K	Buy	88 +59	+203%	+$6.68K	﹤0.01%	355
2016 Q1	$3K	Buy	+29	New	+$2.81K	﹤0.01%	312

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Balentine LLC's ZBH Position: Q3 2022 in Review

Balentine LLC sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 3,516 shares — an estimated $369K sold.

Balentine LLC first reported a position in ZBH in Q1 2016 and held it in 16 quarters. The position peaked at $415K in Q1 2022. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Balentine LLC reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Balentine LLC sold 3,516 Zimmer Biomet shares in Q3 2022, an estimated $369K.
Balentine LLC first reported a position in Zimmer Biomet in Q1 2016 and held it in 16 quarters.
Balentine LLC's Zimmer Biomet position peaked at $415K in Q1 2022.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.